Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
BACKGROUND: Pituitary adenomas are common intracranial neoplasms, comprising 10 - 15% of all brain tumors. Data from autopsy studies suggest that pituitary adenomas develop in 17 - 25% of the population. Nevertheless, the pathogenesis of sporadic pituitary tumors still remains obscure. OBJECTIVE: I...
Main Authors: | Cakir, M, Grossman, AB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
by: Dworakowska, D, et al.
Published: (2009) -
Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
by: Kennedy, A, et al.
Published: (2011) -
Akting and cycling: a tale of the pituitary.
by: Grossman, AB, et al.
Published: (2004) -
Involvement of MAPK/ERK and Akt signaling
pathways in the proliferation of keratinocytes
cocultured with adipose-derived stem cells (ACSS)-Porous
Chitosan Scaffold (PSC)
by: Halim, Ahmad Sukari
Published: (2017) -
Modifying radiosensitivity in tumors: Targeting the Ras-PI-3 kinase pathway.
by: Muschel, R, et al.
Published: (2001)